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Background: Expiratory flow limitation (EFL) during tidal breathing is common in patients with severe COPD, and a
major determinant of dynamic hyperinflation and exercise limitation. EFL can be measured by the forced oscillation
technique (FOT); however, the relevance to clinical parameters is not fully understood. We hypothesized that
emphysema extent and pulmonary function would contribute independently to the degree of EFL.
Methods: Broadband frequency FOT and pulmonary function tests were performed in 74 patients with COPD to
derive respiratory system resistance (Rrs) and reactance (Xrs), and the EFL index as expressed by the differences
between inspiratory and expiratory phases of Xrs at 5 Hz (ΔX5). Emphysema extent was measured by
high-resolution computed tomography and scored.
Results: On the basis of the median value of ΔX5 (0.55 cmH2O/L/s), patients were classified into a high or low EFL
index group. In multivariate regression analyses, a high EFL index was independently predicted by emphysema
score, peripheral airway obstruction (forced expiratory flow between 25% and 75% of forced vital capacity),
hyperinflation (functional residual capacity), and airway caliber (whole-breath Rrs at 5 Hz).
Conclusions: EFL measured by FOT is a global measure of COPD that has separable etiologies and is useful for
evaluating the disease condition.
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Tidal expiratory flow limitation (EFL) occurs when an
increase in transpulmonary pressure causes no increase
in resting expiratory flow. This phenomenon is common
in patients with severe COPD and is a major determinant
of dynamic hyperinflation and exercise limitation [1,2].
Dellacà et al. indicated that the differences between in-
spiratory and expiratory phases of respiratory system
reactance (ΔXrs) measured by the forced oscillation
technique (FOT) allowed the detection of EFL [1]. It is
supposed that Xrs normally reflects the elastic and inertial
properties of the respiratory system but, with flow limi-
tation, oscillatory signals cannot pass through the choke
points and reach the alveoli. During EFL, respiratory sys-
tem resistance (Rrs) and Xrs will reflect the mechanical* Correspondence: toshihiro-shirai@i.shizuoka-pho.jp
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reproduction in any medium, provided the orproperties of airways proximal to the choke points, which
are much stiffer than the periphery, producing a marked
reduction in apparent compliance and a fall in Xrs.
In contrast to the monofrequency FOT used by Dellacà
et al., clinical application of the broadband frequency FOT
has progressed recently with the spread of commercially
available devices: the impulse oscillation system (IOS) [3]
and MostGraph [4]. Several investigators have reported that
ΔXrs, the EFL index, could discriminate between COPD
and asthma [5-7], and between COPD and pulmonary
fibrosis [8]; however, the relevance of EFL to clinical param-
eters is not fully understood. We hypothesized that emphy-
sema extent and pulmonary function would contribute
independently to the degree of EFL in patients with COPD.
In this cross-sectional study we measured the EFL index by
broadband frequency FOT in 74 patients with COPD and
assessed the differences in clinical features between patients
with a high and low EFL index.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Subjects
Seventy-four patients with COPD who attended outpatient
clinics at Shizuoka General Hospital for routine check-ups
between October 2009 and December 2012 were enrolled
in this study. The patients satisfied the definition of the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) [9] and had been receiving medications, including
long-acting antimuscarinic agents, long-acting β2-agonists,
inhaled corticosteroids, or sustained-release theophylline.
They were clinically stable and had had no exacerbations,
defined as increased dyspnea associated with a change in
the quality and quantity of sputum, for at least one month
before the study.
Thirty-nine healthy control subjects without pulmonary
diseases were recruited from our hospital staff. The proto-
cols were approved by the Institutional Review Board of
Shizuoka General Hospital (SGH 11-07-20) and informed
consent was obtained from all subjects prior to the study.
Modified Medical Research Council (mMRC) and COPD
assessment test (CAT)
The mMRC scale was used to evaluate dyspnea in daily liv-
ing, grading 0 (only get breathless with strenuous exercise)
to 4 (too breathless to leave the house or breathless when
dressing) [10].
The CAT (Japanese version, supplied by GlaxoSmithKline
Japan) questionnaire consists of 8 items (cough, phlegm,
chest tightness, breathlessness going up hills/stairs, activity
limitations at home, confidence leaving home, sleep,
and energy) assessing and quantifying the symptoms and
impacts of COPD [11]. Each item is scored from 0 to 5
giving a total score range from 0 to 40, corresponding
to the best and worst health status, respectively.
Measurement of respiratory impedance and pulmonary
function tests
On the same examination day, when their clinical symp-
toms were stable, measurements of respiratory impedance
using FOT and pulmonary function tests were performed
in that order. Short-acting β2 agonists were not used for
more than 12 hours before these tests in every case.
Respiratory impedance was measured with broadband
FOT using a commercially available device (MostGraph-01;
Chest M.I. Co. Ltd., Tokyo, Japan) [4,7] and met standard
recommendations [12]. Impulse oscillatory signals gener-
ated by a loud speaker at intervals of 0.25 seconds were
applied to the respiratory system through the mouthpiece
during tidal breathing at rest. Mouth pressure and flow
signals were measured and calculated to obtain Rrs and
Xrs properties against oscillatory frequency ranging from
4 to 36 Hz. During measurements, the subjects supported
their cheeks firmly to reduce upper airway shunting while
sitting with their neck in a comfortable neutral posture.Since the curves of Rrs and Xrs versus frequency could be
obtained every 0.25 seconds, they were serially lined up
against the time axis with assigned color gradients, result-
ing in colored 3-dimensional imaging patterns.
In the present study, we used Rrs at 5 and 20 Hz
(R5 and R20, respectively), and the difference between R5
and R20 (R5-R20) as an indicator of the frequency depend-
ence of Rrs, which is supposed to reflect inhomogeneous
ventilatory mechanics [13]. We also used Xrs at 5 Hz (X5),
which reflects elastic and inertial properties of the lung,
resonant frequency (Fres) where Xrs crosses zero and the
elastic and inertial forces are equal in magnitude and op-
posite, and a low-frequency reactance area (ALX), which
is the integral of Xrs at 5 Hz to the Fres. Each oscillatory
index is expressed as the mean values during a respiratory
cycle (whole-breath), inspiratory and expiratory phases, and
the differences between inspiratory and expiratory phases
(Δ). In the present study, ΔX5 was used as the EFL index.
Patients were classified into high or low EFL index groups
according to the median value of EFL index.
Spirometry and lung volumes were determined using
computerized equipment (model CHESTAC-8800; Chest
M.I. Co. Ltd., Tokyo, Japan) according to the recommenda-
tions [14,15]. Predicted values for pulmonary function tests,
excluding inspiratory capacity (IC), were obtained from the
Japanese Respiratory Society guidelines [16] and those for
IC were obtained from previous reports [17,18].
Emphysema score
Emphysema was evaluated by high-resolution computed
tomography (HRCT) according to the method reported
previously [8,19]. Briefly, HRCT findings were evaluated
at 3 anatomic levels in both lungs: near the superior
margin of the aortic arch (level of the upper lung field),
at the level of the carina (level of the middle lung field), and
at the level of the orifice of the inferior pulmonary veins
(level of the lower lung field). Emphysema was defined as a
focal region of low attenuation without visible walls. Cysts
were defined as round air spaces with a well-defined wall.
Emphysema with cysts, if any, was scored visually in the 6
fields and summed. The score in each lung field was calcu-
lated according to the percentage of low-attenuation areas
(%LAA): score 0, %LAA <5%; score 1, %LAA ≥5%– < 25%;
score 2, %LAA ≥25%– < 50%; score 3, %LAA ≥50%– < 75%;
and score 4, %LAA ≥75%. The threshold level between
the normal lung density area and LAA was defined
as −950 Hounsfield units on the basis of our previous study
[8]. Thus, the total emphysema scores ranged from 0 to 24.
Statistical analysis
Comparisons among groups were made using the
Kruskal-Wallis test, followed by multiple comparisons
among groups using the Mann–Whitney U test. The
chi-square or Fisher’s exact test was used to test significance
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tients in various categories. Correlations between variables
were performed using the Spearman rank correlation coef-
ficient. Multivariate logistic regression analyses were per-
formed to adjust for effects among multiple variables for
elevation of the EFL index (ΔX5). Model selection was
made by the best subset selection procedure using Akaike’s
information criteria (AIC). Stat View Version 5.0 (SAS
Institute, Cary, NC, USA) and R version 2.15.2 (R Founda-
tion for Statistical Computing, Vienna, Austria, 2012) were
used for statistical calculations. A p value of <0.05 was
considered significant, and all tests were 2 sided.
Results
The clinical characteristics of the subjects, pulmonary
function tests, and forced oscillatory parameters are shown
in Tables 1 and 2. The frequency distribution of the EFL
index (ΔX5) in 74 patients is shown in Figure 1. According
to the median value of 0.55 (cmH2O/L/s), 74 patientsTable 1 Characteristics of the study subjects
Patients with COPD n = 74 High EFL in
Age (years) 73 (54 – 86) 73
Gender (male/female) 71/3
Body mass index (kg/m2) 21.1 (15.2 – 32.3) 21.6 (
Current/ex/never smoker 9/65/0 4
Pack years 53.1 (5.0 – 150.0) 62.0 (5
mMRC scale 1 (0 – 4) 2
CAT score 12.5 (0 – 32) 14
Emphysema score 10 (0 – 23) 12
GOLD I/II/III/IV 9/31/20/14 1/9
LAMA 26
LABA 4
LAMA + LABA 26
LAMA + ICS/LABA 13
Sustained-release theophylline 24
FEV1 (% predicted) 52.6 (17.8 – 108.0) 36.8 (17
FVC (% predicted) 81.4 (34.9 – 144.0) 75.6 (34
FEV1/FVC (%) 50.1 (28.7 – 69.9) 42.0 (2
IC (% predicted) 83.0 (38.5 – 124.8) 78.4 (38
FEF 25-75% (% predicted) 18.6 (5.7 – 57.4) 10.1 (5
FRC (% predicted) 100.1 (56.9 – 165.5) 111.9 (6
RV (% predicted) 149.0 (34.4 – 332.0) 182.4 (9
TLC (% predicted) 109.0 (75.9 – 152.2) 116.9 (7
RV/TLC (% predicted) 118.2 (35.7 – 180.7) 135.5 (7
Values are shown as a median (range) or numbers.
Abbreviations: CAT COPD assessment test, EFL expiratory flow limitation, FEF 25-75%
volume in 1 second, FRC functional residual capacity, FVC forced vital capacity, GOL
ICS inhaled corticosteroids, LABA long-acting β2-agonists, LAMA long-acting antimus
RV residual volume, TLC total lung capacity.
*p <0.05 versus controls, †p <0.05 versus low EFL index group.with COPD were classified into two groups, with 37 pa-
tients each with a high and low EFL index. mMRC scale,
functional residual capacity (FRC), residual volume (RV),
total lung capacity (TLC), and RV/TLC were significantly
higher and forced expiratory volume in 1 second (FEV1),
forced vital capacity (FVC), FEV1/FVC, IC, and forced ex-
piratory flow between 25% and 75% of FVC (FEF 25-75%)
were lower in the high EFL index group than in the low
EFL index group. Whole-breath, inspiratory, and expiratory
R5, R20, R5-R20, Fres, and ALX, and ΔX5 were signifi-
cantly higher and whole-breath, inspiratory, and expiratory
X5, Δ(R5-R20), ΔFres, and ΔALX were lower in the high
EFL index group than in the low EFL index group. There
was no difference in CAT and emphysema scores between
the 2 groups. Figure 2 shows typical colored 3-dimensional
images of Rrs and Xrs in each representative patient with a
high or low EFL index.
The control subjects were significantly younger, with no
male dominance, more nonsmokers, fewer pack-years, anddex group n = 37 Low EFL index group n = 37 Controls n = 39
(62 – 84)* 73 (54 – 86)* 35 (24 – 69)
35/2* 36/1* 19/20
15.6 – 32.3) 20.8 (15.2 – 27.7) 22.0 (16.9 – 30.8)
/33/0* 5/32/0* 4/9/26
.0 – 132.0)* 51.3 (7.5 – 150.0)* 0.0 (0.0 – 33.0)
(0 – 4)† 1 (0 – 4) NA
(3 – 32) 11 (0 – 30) NA







.8 – 108.0)†* 67.5 (20.0 – 93.8)* 100.0 (76.9 – 118.5)
.9 – 144.0)†* 91.4 (42.5 – 114.9)* 102.7 (82.5 – 123.1)
8.7 – 66.8)†* 59.2 (30.4 – 69.9)* 84.2 (73.5 – 97.7)
.5 – 121.6)†* 86.7 (53.6 – 124.8) 94.2 (62.5 – 146.4)
.7 – 37.7)†* 28.5 (6.3 – 57.4)* 83.4 (45.8 – 114.3)
5.4 – 165.5)† 85.8 (56.9 – 123.4)* 107.9 (66.2 – 138.4)
4.0 – 332.0)†* 133.1 (34.4 – 213.6)* 94.4 (65.1 – 239.6)
6.5 – 152.2)† 101.5 (75.9 – 133.2) 107.9 (84.2 – 147.5)
1.8 – 180.7)†* 106.2 (35.7 – 162.9) 112.3 (68.7 – 168.5)
forced expiratory flow between 25% and 75% of FVC, FEV1 forced expiratory
D Global Initiative for Chronic Obstructive Lung Disease, IC inspiratory capacity,
carinic agents, mMRC modified Medical Research Council, NA not applicable,
Table 2 Comparison of forced oscillatory parameters
Patients with
COPD n = 74
High EFL index
group n = 37
Low EFL index
group n = 37
Controls n = 39
R5 (cmH2O/L/s) Whole breath 4.36 (1.58 – 8.06) 5.09 (2.45 – 8.06)†* 3.51 (1.58 – 7.99)* 2.79 (1.15 – 5.70)
Inspiratory 3.80 (1.57 – 8.16) 4.80 (1.90 – 8.16)†* 3.11 (1.57 – 7.64)* 2.48 (1.01 – 5.03)
Expiratory 4.78 (1.60 – 10.45) 5.55 (2.86 – 10.45)†* 4.17 (1.60 – 8.34)* 3.04 (1.29 – 6.36)
ΔR5 −0.78 (−5.51 – 0.45) −0.98 (−5.51 – 0.45) −0.70 (−2.71 – 0.36) −0.54 (−2.39 – 0.16)
R20 (cmH2O/L/s) Whole breath 3.21 (1.45 – 6.41) 3.59 (1.77 – 6.00)†* 2.86 (1.45 – 6.41)* 2.57 (1.20 – 4.20)
Inspiratory 3.03 (1.44 – 6.56) 3.38 (1.79 – 5.27)†* 2.56 (1.44 – 6.56)* 2.47 (1.14 – 3.76)
Expiratory 3.41 (1.52 – 7.66) 3.72 (1.73 – 7.66)†* 3.08 (1.52 – 6.26)* 2.69 (1.26 – 4.84)
ΔR20 −0.29 (−3.31 – 0.34) −0.32 (−3.31 – 0.34) −0.28 (−1.72 – 0.30) −0.28 (−1.3 – 0.29)
R5-R20 (cmH2O/L/s) Whole breath 1.22 (−0.04 – 2.96) 1.51 (0.50 – 2.96)†* 0.64 (−0.04 – 1.83)* 0.25 (−0.76 – 1.76)
Inspiratory 0.82 (−0.10 – 2.89) 1.32 (0.11 – 2.89)†* 0.39 (−0.10 – 1.99)* 0.11 (−0.96 – 1.27)
Expiratory 1.42 (0.02 – 3.52) 1.99 (0.88 – 3.52)†* 0.78 (0.02 – 2.08)* 0.36 (−0.57 – 2.24)
Δ(R5-R20) −0.50 (−2.20 – 0.32) −0.68 (−2.20 – 0.30)†* −0.31 (−1.05 – 0.32) −0.29 (−1.15 – −0.04)
X5 (cmH2O/L/s) Whole breath −1.23 (−6.92 – 0.17) −2.77 (−6.92 – −0.48)†* −0.42 (−3.50 – 0.17)* −0.29 (−1.48 – 0.20)
Inspiratory −0.78 (−3.85 – 0.09) −1.57 (−3.85 – −0.11)†* −0.42 (−3.24 – 0.09)* −0.33 (−1.33 – 0.18)
Expiratory −1.63 (−11.17 – 0.25) −3.74 (−11.17 – -0.85)†* −0.37 (−3.77 – 0.25)* −0.23 (−1.64 – 0.21)
ΔX5 0.55 (−0.47 – 8.50) 1.80 (0.59 – 8.50)†* −0.03 (−0.47 – 0.54) −0.06 (−0.37 – 0.48)
Fres (Hz) Whole breath 13.74 (4.23 – 26.52) 19.61 (7.91 – 26.52)†* 7.97 (4.23 – 25.96)* 6.53 (4.03 – 14.89)
Inspiratory 10.87 (4.46 – 27.07) 16.10 (5.76 – 24.83)†* 8.16 (4.46 – 27.07)* 6.71 (4.05 – 12.36)
Expiratory 16.10 (4.00 – 28.20) 22.27 (10.06 – 28.20)†* 7.82 (4.00 – 24.85)* 6.30 (4.00 – 17.42)
ΔFres −2.33 (−15.00 – 2.98) −6.34 (−15.00 – −0.08)†* 0.14 (−5.74 – 2.98) 0.17 (−5.37 – 1.75)
ALX (cmH2O/L/s x Hz) Whole breath 7.44 (0.04 – 62.87) 22.16 (1.96 – 62.87)†* 1.42 (0.04 – 33.88)* 0.92 (0.01 – 7.64)
Inspiratory 3.54 (0.07 – 45.55) 10.60 (0.37 – 45.55)†* 1.48 (0.07 – 32.92)* 1.02 (0.01 – 6.47)
Expiratory 11.34 (0.00 – 106.35) 32.20 (3.54 – 106.35)†* 1.19 (0.00 – 34.83)* 0.74 (0.00 – 8.87)
ΔALX −3.31 (−86.95 – 2.35) −15.51 (−86.95 – 0.00)†* 0.05 (−5.73 – 2.35) 0.15 (−3.96 – 1.11)
Values are shown as a median (range).
Abbreviations: ALX integrated low-frequency reactance area, Δ difference between inspiratory and expiratory phases, EFL expiratory flow limitation, Fres resonant
frequency, R5 and R20 respiratory system resistance at 5 Hz and 20 Hz, R5-R20 difference between R5 and R20, X5 respiratory system reactance at 5 Hz.
*p <0.05 versus controls, †p <0.05 versus low EFL index group.
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ence in the body mass index. Concerning forced oscillatory
parameters, the control subjects had lower whole-breath,
inspiratory, and expiratory R5, R20, R5-R20, Fres, and
ALX values and less negative X5 values than patients
with COPD; however, there was no difference in ΔRrs,
ΔX5 (EFL index), ΔFres, and ΔALX values between COPD
patients with a low EFL index and controls.
We constructed a model from variables as follows: age,
smoking history (pack-years), symptoms (mMRC and CAT),
emphysema extent, spirometry (FEV1, FVC, FEV1/FVC,
IC, and FEF 25-75%), lung volumes (FRC, RV, TLC,
and RV/TLC), and Rrs (whole-breath R5 and R20, and
ΔR5 and ΔR20). The univariate correlations between ΔX5
(EFL index) and predictor variables are shown in Table 3.
ΔX5 (EFL index) correlated positively with the mMRC
scale, FRC, RV, TLC, RV/TLC, R5, and R20, and negatively
with FEV1, FVC, FEV1/FVC, and FEF 25-75%, but not with
age, pack-years, CAT and emphysema scores, IC, ΔR5, orΔR20. Multivariate logistic regression analysis of the high
EFL index (ΔX5) was performed using the selected model
including 7 variables (AIC = 53.3, Table 4). The high
EFL index was independently predicted by the emphysema
score, FEF 25-75%, FRC, and whole-breath R5, but not
by mMRC, FEV1/FVC, and ΔR5. Unlike univariate analysis,
multivariate analysis revealed that severe emphysema
related to the high EFL index.
Discussion
We assessed whether emphysema extent and pulmonary
functions contributed independently to the degree of EFL
measured by broadband FOT in 74 patients with COPD. It
was found that the high EFL index was independently
predicted by emphysema extent as measured by HRCT,
peripheral airway obstruction as expressed by FEF 25-75%,
hyperinflation as expressed by FRC, and airway caliber
as expressed by whole-breath R5. These results suggest
that EFL measured by FOT is a global measure of COPD
Figure 1 Frequency distribution of the EFL index (ΔX5) in 74
patients with COPD. The patients were classified into high or low
EFL index groups according to the median value of 0.55 (cmH2O/L/s)
(dotted line). Abbreviations: ΔX5, difference between inspiratory and
expiratory respiratory system reactance; EFL, expiratory flow limitation.
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used for stratifying patients and evaluating the severity of
their disease or treatment response.
We consider respiratory impedance measured by FOT
useful in research and clinical practice for the following
reasons. First, it is performed during tidal breathing and
does not require specific maneuvers or noticeable interfer-
ence with respiration. Secondly, it provides informationFigure 2 Colored 3-dimensional images of Rrs and Xrs in each repres
dependence (Rrs was higher and Xrs shifted more negative in the expirato
(Rrs increased at lower frequencies and fell with increasing frequencies) we
moderate over the entire frequency and respiratory cycle, and Xrs shifted s
expiratory flow limitation; Rrs, respiratory system resistance; Xrs, respiratorythat is applicable to resting conditions or daily activities.
Thirdly, it can be performed under different breathing
conditions, such as deep expiration, and so provides infor-
mation about the mechanical properties of the respiratory
system that can be complementary to spirometry. Recent
studies indicate that not only whole-breath but within-
breath analyses of respiratory impedance bring useful in-
formation on the pathophysiology of COPD and asthma.
On the basis of the report by Dellacà et al. that ΔX5 is a
surrogate marker for EFL, we found that within-breath
changes in Xrs (ΔX5 and ΔFres) discriminated between
patients with COPD and asthma [7]. Other investigators
obtained similar results with the IOS, a slight different
method of FOT from the method in the present study [5,6].
Thus, these results indicate that EFL measured by FOT is a
useful measure to diagnose COPD.
In the present study, we confirmed that the emphysema
extent as measured by HRCT was an independent pre-
dictor of the degree of EFL (ΔX5), suggesting that re-
duced lung elastic recoil due to emphysema may be a
cause of EFL. We previously showed that ΔX5 values
in 86 patients with COPD were significantly higher
than those in 45 patients with pulmonary fibrosis, pos-
sibly because the latter has increased lung elastic recoil
(mean, 1.23 vs −0.18 cmH2O/L/s, respectively: p <0.05)
[8]. There have been only a few published studies con-
cerning the relationship between respiratory imped-
ance and emphysema on HRCT. Crim et al. found a poorentative patient with high or low EFL index. Respiratory cycle
ry phases than in the inspiratory phases) and frequency dependence
re marked in patients with high EFL index. In contrast, Rrs was
lightly negative in patients with low EFL index. Abbreviations: EFL,
system reactance.
Table 3 Univariate correlations between ΔX5 (EFL index)
and predictor variables
Rho p value
Age (years) 0.087 0.4556
Pack-years 0.181 0.1217
mMRC scale 0.282 0.0161
CAT score 0.084 0.4712
Emphysema score 0.107 0.3609
FEV1 (% predicted) −0.526 <0.0001
FVC (% predicted) −0.365 0.0018
FEV1/FVC (%) −0.518 <0.0001
IC (% predicted) −0.212 0.0707
FEF 25-75% (% predicted) −0.640 <0.0001
FRC (% predicted) 0.427 0.0003
RV (% predicted) 0.443 0.0002
TLC (% predicted) 0.245 0.0363
RV/TLC (% predicted) 0.448 0.0001
Whole-breath R5 (cmH2O/L/s) 0.669 <0.0001
ΔR5 (cmH2O/L/s) −0.211 0.0709
Whole-breath R20 (cmH2O/L/s) 0.528 <0.0001
ΔR20 (cmH2O/L/s) −0.007 0.9539
Values are the Spearman rank correlation coefficient.
Abbreviations: CAT COPD assessment test, Δ difference between inspiratory and
expiratory phases, R5 and R20 respiratory system resistance at 5 Hz and 20 Hz, EFL
expiratory flow limitation, FEF 25-75% forced expiratory flow between 25% and 75%
of FVC, FEV1 forced expiratory volume in 1 second, FRC functional residual capacity,
FVC forced vital capacity, IC inspiratory capacity, mMRC modified Medical Research
Council, NA not applicable, RV residual volume, TLC total lung capacity.
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tent and Rrs and Xrs measured by IOS in a large study
but they did not analyze within-breath changes [20]. Tim-
mins et al. also reported that there was no correlation
between emphysema extent and ΔX6 measured by their
in-house monofrequency FOT device [21]. Consistent with
these reports, there was no correlation in univariate analysisTable 4 Multivariate logistic regression analyses for






mMRC scale 0.969 0.412 – 2.282 0.9432
Emphysema score 1.296 1.013 – 1.659 0.0395
FEV1/FVC (%) 1.197 0.980 – 1.461 0.0777
FEF25-75% (% predicted) 0.752 0.590 – 0.960 0.0220
FRC (% predicted) 1.108 1.039 – 1.181 0.0017
R5 (cmH2O/L/s) 3.426 1.470 – 7.983 0.0043
ΔR5 (cmH2O/L/s) 0.423 0.134 – 1.342 0.1443
Abbreviations: Δ difference between inspiratory and expiratory phases, R5
respiratory system resistance at 5 Hz, EFL expiratory flow limitation, FEV1
forced expiratory volume in 1 second, FVC forced vital capacity, FEF 25-75%
forced expiratory flow between 25% and 75% of FVC, FRC functional residual
capacity, mMRC modified Medical Research Council.in the present study, but multivariate analysis revealed that
severe emphysema related to the high EFL index, indicating
the need to control for confounding factors.
We also confirmed in the present study that whole-
breath R5 was the strongest predictor of the degree of
EFL (ΔX5), but not ΔR5. Rrs reflects dissipative mechan-
ical property of the lung [12], in other words, viscous re-
sistance. As airway obstruction increases in COPD, Rrs
rises and becomes more frequency dependent, especially
at lower frequencies [22], implying that R5 is supposed to
be a measure of airway caliber. Timmins et al. also found
a strong correlation between R6 and EFL index [21], while
Dellacà et al. confirmed that ΔR5, in contrast to ΔX5, was
not associated with EFL [1].
There was an independent association between FEF
25-75% and EFL index; the lower the FEF 25-75%, the
higher the EFL index. When the flow-volume curve be-
comes more concave because of highly reduced flow in the
effort-independent part of the curve, the degree of EFL
increases; however, there was no association between
FEV1/FVC and EFL index in multivariate analysis. These
results suggest that the EFL index measured by FOT during
tidal breathing reflects peripheral airway obstruction as
measured by forced expiration. FRC, a measure of hyperin-
flation, was also an independent predictor of the EFL index
in the present study, whereas Timmins et al. found no
correlation. Possible explanations include the difference
in the sample size or the FOT method.
We classified the patients into high or low EFL index
groups according to the median value of the EFL index
(0.55 cmH2O/L/s) of patients with COPD. Although all
the control subjects had lower values than this cutoff
level, this was not a genuine threshold value for detecting
EFL. Dellacà et al. established a threshold value of
2.8 cmH2O/L/s for the detection of EFL, which was proven
by esophageal manometry with high sensitivity and
specificity [1]; however, our results were obtained with a
broadband FOT device, MostGraph, whereas Dellacà et al.
used their in-house monofrequency FOT. Therefore,
the threshold value identified by Dellacà et al. may not be
applicable to our patients and would have to be established
for MostGraph by further studies.
Since the FOT device used in the present study can
provide colored 3-dimensional images of respiratory
impedance [7,23], the difference in the images between
patients with a high and low EFL index was distinct. This
technique enables rapid perception of the disease condition
rather than comparing each value, and would be useful if
applied more widely in real clinical practice.
GOLD recommends the use of the mMRC scale or CAT
to assess symptoms in patients with COPD; however, there
was a difference in the analysis between these parameters
in the present study. The univariate correlations in Table 3
showed that ΔX5 (EFL index) correlated positively with the
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scale was higher in the high EFL index group than in the
low EFL index group, but there was no difference in CAT
score between the 2 groups. A possible explanation may
be that the mMRC is a unidimensional measurement to
quantify only dyspnea whereas the CAT score is a multidi-
mensional method, which assess 8 items; not only dyspnea
but also other symptoms and health status [24].
Methods for assessing EFL include not only FOT but
also negative expiratory pressure (NEP), both of which
are simple, noninvasive, and practical techniques [2]. A
previous study found a good agreement between FOT
and NEP despite some differences in detection of EFL [25];
however, the relationship between these techniques and
NEP has not been fully understood. Further studies are
needed to clarify this matter.
Conclusions
The risk of EFL is independently predicted by emphysema
extent, peripheral airway obstruction, hyperinflation, and
airway caliber. EFL measured by FOT is a global measure
of COPD and is useful for evaluating the disease condition.
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